MedTrace Logo

A Study to Evaluate Gepotidacin Exposure in Breast Milk of Healthy Lactating Women

NCT07645235 · Status: NOT_YET_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2026-06-12

No results posted yet for this study

Summary

This study aims to evaluate the pharmacokinetic of gepotidacin in fed healthy lactating women.

Conditions

Interventions

DRUG

Gepotidacin

A single oral dose of 3000 mg gepotidacin will be administered

Sponsors & Collaborators

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-07-09
Primary Completion
2027-05-05
Completion
2027-05-13
FDA Drug
Yes

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07645235 on ClinicalTrials.gov